Drug-free nasal spray as a barrier against SARS-CoV-2 infection: safety and efficacy in human nasal airway epithelia
F. Fais, R. Juskeviciene, V. Francardo, S. Mateos, S. Constant, M. Borelli, I. P. Hohenfeld, T. Meyer
This study tests a nasal spray (AM-301) for safety and efficacy against SARS-CoV-2 infection in human nasal epithelial models, finding it safe and significantly reduces viral titer.
bioRxiv · Jul 12, 2021 · PreprintPharmacology & Toxicology